Media Contact
Amanda Galgay
Corporate Communications & Investor Relations
617-804-6659
amanda.galgay@peartherapeutics.com
Press Releases
- Pear Therapeutics to Present at the 21st Annual Needham Growth Conference January 11, 2019
- Sandoz and Pear Therapeutics Announce US Launch of reSET-O™ to Help Treat Opioid Use Disorder January 7, 2019
- Pear Therapeutics Completes $64M Series C Financing January 4, 2019
- Pear Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference January 2, 2019
- Pear Therapeutics Announces Initiation of Proof of Concept Study for Prescription Digital Therapeutic in Development for the Treatment of Schizophrenia December 17, 2018
- Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder December 10, 2018